Design, Synthesis and Biological Assessment of N ′-(2-Oxoindolin-3-ylidene)-6-methylimidazo[2,1- b ]thiazole-5-carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer.

MLA

Alshaye, Najla A., et al. “Design, Synthesis and Biological Assessment of N ′-(2-Oxoindolin-3-Ylidene)-6-Methylimidazo[2,1- b ]Thiazole-5-Carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer.” Pharmaceuticals (14248247), vol. 17, no. 2, Feb. 2024, p. 216. EBSCOhost, https://doi.org/10.3390/ph17020216.

APA

Alshaye, N. A., Elgohary, M. K., Elkotamy, M. S., & Abdel-Aziz, H. A. (2024). Design, Synthesis and Biological Assessment of N ′-(2-Oxoindolin-3-ylidene)-6-methylimidazo[2,1- b ]thiazole-5-carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer. Pharmaceuticals (14248247), 17(2), 216. https://doi.org/10.3390/ph17020216

Chicago

Alshaye, Najla A., Mohamed K. Elgohary, Mahmoud S. Elkotamy, and Hatem A. Abdel-Aziz. 2024. “Design, Synthesis and Biological Assessment of N ′-(2-Oxoindolin-3-Ylidene)-6-Methylimidazo[2,1- b ]Thiazole-5-Carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer.” Pharmaceuticals (14248247) 17 (2): 216. doi:10.3390/ph17020216.